Accendra Health Inc (ACH)

Currency in USD
3.20
-0.02(-0.66%)
Real-time Data·
ACH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.143.22
52 wk Range
1.849.08
Key Statistics
Prev. Close
3.22
Open
3.15
Day's Range
3.14-3.22
52 wk Range
1.84-9.08
Volume
128.16K
Average Volume (3m)
812.06K
1-Year Change
-64.4205%
Book Value / Share
-6.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.49
Upside
+40.31%
Members' Sentiments
Bearish
Bullish
ProTips
Management has been aggressively buying back shares

Accendra Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

2 Buy
2 Hold
2 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 4.49
(+40.31% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold4.00+25.39%7.00DowngradeNov 03, 2025
Leerink Partners
Hold6.00+88.09%5.00MaintainOct 08, 2025
JPMorgan
Sell6.00+88.09%7.00MaintainAug 27, 2025
UBS
Buy7.00+119.44%13.00MaintainAug 13, 2025
Baird
Buy7.00+119.44%10.00MaintainAug 12, 2025

Accendra Health Inc SWOT Analysis


Strategic Expansion
Explore Owens & Minor's $1.36 billion acquisition of Rotech, aimed at strengthening its position in the high-growth Patient Direct business
Financial Challenges
Delve into the company's mixed Q3 results, revised guidance, and the implications of its recent CFO transition on financial stability
Market Dynamics
Learn how Owens & Minor navigates industry shifts, including the impact of GLP-1 drugs and potential benefits from Chinese tariffs
Analyst Perspectives
Discover varied analyst views on OMI's future, with price targets ranging from $14 to $23, reflecting both optimism and caution
Read full SWOT analysis

Accendra Health Inc Earnings Call Summary for Q1/2026

  • Accendra Health reported Q1 2026 EPS of -$0.04, beating estimates of -$0.101 by 60.4%; revenue missed at $627.8M vs. $646.24M forecast.
  • Stock surged 8.66% in premarket trading; gross margins improved from 19% to nearly 50% following separation from Owens & Minor.
  • Revenue declined 6.8% YoY due to large commercial payer exit; organic growth approximately 1% excluding this impact.
  • Company maintains 2026 guidance, expects 65%+ of adjusted EBITDA in Q3-Q4; analysts forecast profitability with $0.71 EPS for full year.
  • Strategic focus on sleep therapy initiatives driving growth; anticipates higher interest expenses in H2 2026 amid ongoing cost reduction efforts.
Last Updated: 2026-05-11, 09:34 a/m
Read Full Transcript

Earnings

Latest Release
May 11, 2026
EPS / Forecast
-0.04 / -0.10
Revenue / Forecast
627.8M / 646.24M
EPS Revisions
Last 90 days

ACH Income Statement

Compare ACH to Peers and Sector

Metrics to compare
ACH
Peers
Sector
Relationship
P/E Ratio
−2.3x−10.9x−0.4x
PEG Ratio
0.010.090.00
Price/Book
−0.5x2.0x2.6x
Price / LTM Sales
0.1x1.1x3.0x
Upside (Analyst Target)
39.8%34.2%49.7%
Fair Value Upside
Unlock24.5%7.3%Unlock

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
24.28M31.71%88.39M
Other Institutional Investors
51.56M67.33%187.69M
Public Companies & Retail Investors
736.15K0.96%2.68M
Total
76.58M100.00%278.76M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Coliseum Capital Management, LLC17.11%13,100,80747,687
Coliseum Capital Partners LP13.92%10,657,33738,793

People Also Watch

54.34
DK
+3.86%
30.49
GLOB
-3.66%
11.435
COMP
-3.75%
4.74
MGNX
-0.21%
50.62
PKX
-1.23%

FAQ

What Is the Accendra Health (ACH) Stock Price Today?

The Accendra Health stock price today is 3.20 USD.

What Stock Exchange Does Accendra Health Trade On?

Accendra Health is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Accendra Health?

The stock symbol for Accendra Health is "ACH."

What Is the Accendra Health Market Cap?

As of today, Accendra Health market cap is 245.07M USD.

What Is Accendra Health's Earnings Per Share (TTM)?

The Accendra Health EPS (TTM) is -1.37.

When Is the Next Accendra Health Earnings Date?

Accendra Health will release its next earnings report on Jul 31, 2026.

From a Technical Analysis Perspective, Is ACH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Accendra Health Stock Split?

Accendra Health has split 4 times.

How Many Employees Does Accendra Health Have?

Accendra Health has 6500 employees.

What is the current trading status of Accendra Health (ACH)?

As of Jul 08, 2026, Accendra Health (ACH) is trading at a price of 3.20 USD, with a previous close of 3.22 USD. The stock has fluctuated within a day range of 3.14 USD to 3.22 USD, while its 52-week range spans from 1.84 USD to 9.08 USD.

What Is Accendra Health (ACH) Price Target According to Analysts?

The average 12-month price target for Accendra Health is 4.49 USD, with a high estimate of 6 USD and a low estimate of 2.7 USD. 2 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +40.31% Upside potential.

What Is the ACH Premarket Price?

ACH's last pre-market stock price is 3.36 USD. The pre-market share volume is 170.00, and the stock has decreased by 0.14, or 4.35%.

What Is the ACH After Hours Price?

ACH's last after hours stock price is 3.38 USD, the stock has decreased by 0.16, or 4.97%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.